Table 2.
Mean IL-30 level by age and sex in the psoriatic and control groups.
| N | Mean IL-30 | (±SD) | Mean rank | p† | |
|---|---|---|---|---|---|
| Psoriasis | |||||
| Age (years) | |||||
| <40 | 10 | 72.94 | (±97.41) | 12.40 | |
| 40–49 | 6 | 104.73 | (±135.19) | 11.50 | |
| ≥50 | 10 | 155.32 | (±196.87) | 15.80 | 0.467 |
| Sex | |||||
| Male | 18 | 106.65 | (±159.96) | 12.72 | |
| Female | 8 | 123.90 | (±132.70) | 15.25 | 0.437 |
| Control | |||||
| Age (years) | |||||
| <40 | 13 | 40.77 | (±63.93) | 14.54 | |
| 40–49 | 4 | 6.06 | (±3.72) | 11.13 | |
| ≥50 | 9 | 35.95 | (±57.99) | 13.06 | 0.720 |
| Sex | |||||
| Male | 12 | 29.30 | (±51.95) | 13.75 | |
| Female | 14 | 37.59 | (±61.78) | 13.29 | 0.877 |
IL-30, interleukin-30; SD, standard deviation. †By Kruskal–Wallis test.